Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2022-4255
2. Registrant Information.
Registrant Reference Number: M-776608-01-1
Registrant Name (Full Legal Name no abbreviations): Bayer CropScience Inc.
Address: Suite 200, 160 Quarry Park Boulevard SE
City: CALGARY
Prov / State: AB
Country: Canada
Postal Code: T2C 3G3
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No.
PMRA Submission No.
EPA Registration No. Unknown
Product Name:
- Active Ingredient(s)
- PROTHIOCONAZOLE
- SPIROXAMINE
- TRIFLOXYSTROBIN
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Prothioconazole + spiroxamine + trifloxystrobin EC 280.3 (93.3+107+80 g/L) - Repeated exposure of honey bee larvae (Apis mellifera L.) under laboratory conditions
Date 23-SEP-21
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Increased health or environmental risk
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
Study is a honey bee larval chronic study (OECD 239) using a formulated product with multiple active ingredients. Based individual component toxicity studies, only one active ingredient is expected to result in toxicity to honey bee larvae. The NOED when expressed in terms of this active ingredient is lower than that for the single compound study.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here
This formulation or a formulation with this combination of active ingredients are not currently registered in Canada, although the individual active ingredients are.